Oxytocin as a possible mediator of SSRI-induced antidepressant effects

[1]  V. Hillegaart,et al.  Sexual Motivation Promotes Oxytocin Secretion in Male Rats , 1998, Peptides.

[2]  K. Uvnäs‐Moberg,et al.  OXYTOCIN MAY MEDIATE THE BENEFITS OF POSITIVE SOCIAL INTERACTION AND EMOTIONS 1 The purpose of this paper is to describe the neuroendocrine mechanisms of positive social interactions. 1 , 1998, Psychoneuroendocrinology.

[3]  D. Stein,et al.  Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia. , 1998, Journal of affective disorders.

[4]  Kerstin Uvnäs-Moberg,et al.  Antistress Pattern Induced by Oxytocin. , 1998, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[5]  P. Gustavsson,et al.  Oxytocin, prolactin, milk production and their relationship with personality traits in women after vaginal delivery or Cesarean section. , 1998, Journal of psychosomatic obstetrics and gynaecology.

[6]  C. Nemeroff,et al.  Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. , 1997, The Journal of pharmacology and experimental therapeutics.

[7]  S L Lightman,et al.  Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. , 1997, Endocrinology.

[8]  L. Heimer,et al.  Substantia innominata: a notion which impedes clinical–anatomical correlations in neuropsychiatric disorders , 1997, Neuroscience.

[9]  J. Panksepp,et al.  Brain Systems for the Mediation of Social Separation‐Distress and Social‐Reward Evolutionary Antecedents and Neuropeptide Intermediaries a , 1997, Annals of the New York Academy of Sciences.

[10]  KERSTIN UVNÄS‐MOBERG,et al.  Physiological and Endocrine Effects of Social Contact , 1997, Annals of the New York Academy of Sciences.

[11]  D. Witt.  Regulatory Mechanisms of Oxytocin‐Mediated Sociosexual Behavior , 1997, Annals of the New York Academy of Sciences.

[12]  M. Altemus,et al.  Integrative Functions of Lactational Hormones in Social Behavior and Stress Management a , 1997, Annals of the New York Academy of Sciences.

[13]  O. Wolkowitz,et al.  Serotonergic Intervention Increases Affiliative Behavior in Humans , 1997, Annals of the New York Academy of Sciences.

[14]  P. Keck,et al.  New uses for antidepressants: social phobia. , 1997, The Journal of clinical psychiatry.

[15]  V. Hillegaart,et al.  Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat , 1996, Neuropharmacology.

[16]  A. Awad,et al.  Psychopharmacology: The Fourth Generation of Progress , 1998, CNS Spectrums.

[17]  M. McCarthy,et al.  An Anxiolytic Action of Oxytocin is Enhanced by Estrogen in the Mouse , 1996, Physiology & Behavior.

[18]  T. Lundeberg,et al.  Oxytocin Causes a Long-Term Decrease of Blood Pressure in Female and Male Rats , 1996, Physiology & Behavior.

[19]  Maria Petersson,et al.  Oxytocin increases nociceptive thresholds in a long-term perspective in female and male rats , 1996, Neuroscience Letters.

[20]  S. Ahlénius,et al.  The oxytocin receptor antagonist 1-deamino-2-d-Tyr-(OEt)-4-Thr-8-Orn-oxytocin inhibits effects of the 5-HT1A receptor agonist 8-OH-DPAT on plasma levels of insulin, cholecystokinin and somatostatin , 1996, Regulatory Peptides.

[21]  Kerstin Uvnäs-Moberg,et al.  Neuroendocrinology of the mother—child interaction , 1996, Trends in Endocrinology & Metabolism.

[22]  S. Stanford,et al.  Prozac: panacea or puzzle? , 1996, Trends in pharmacological sciences.

[23]  T. W. Greidanus,et al.  The role of limbic vasopressin and oxytocin in social recognition , 1996, Brain Research.

[24]  N. Varney,et al.  Psychopharmacology: The Fourth Generation of Progress. , 1996 .

[25]  1996 Receptor and ion channel nomenclature supplement. , 1996, Trends in pharmacological sciences.

[26]  K. Kobak,et al.  Sertraline for social phobia: a double-blind, placebo-controlled crossover study. , 1995, The American journal of psychiatry.

[27]  R. Olson,et al.  The Tyr-MIF-1 family of peptides , 1994, Neuroscience & Biobehavioral Reviews.

[28]  A. Steiger,et al.  Reduction of plasma oxytocin levels in patients suffering from major depression. , 1995, Advances in experimental medicine and biology.

[29]  V. Hillegaart,et al.  High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats , 1994, Pharmacology Biochemistry and Behavior.

[30]  A. Kastin,et al.  Improvement in major depression after low subcutaneous doses of MIF-1. , 1994, Journal of affective disorders.

[31]  K. Uvnäs‐Moberg,et al.  Intracerebroventricularly administered corticotropin-releasing factor releases somatostatin through a cholinergic, vagal pathway in freely fed rats. , 1994, Acta physiologica Scandinavica.

[32]  W. Banks,et al.  Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: Comparison with morphine , 1994, Peptides.

[33]  G. Battaglia,et al.  Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats , 1993, Brain Research.

[34]  T. Lundeberg,et al.  The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms. , 1993, Acta physiologica Scandinavica.

[35]  L. D. van de Kar,et al.  Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). , 1993, The Journal of pharmacology and experimental therapeutics.

[36]  G. Bagdy,et al.  Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat , 1993, Brain Research.

[37]  E. Tribollet,et al.  Localization of binding sites for oxytocin in the brain of the golden hamster. , 1992, Neuroreport.

[38]  V. Hillegaart,et al.  Oxytocin reduces exploratory motor behaviour and shifts the activity towards the centre of the arena in male rats. , 1992, Acta physiologica Scandinavica.

[39]  T. Insel,et al.  Oxytocin Receptor Distribution Reflects Social Organization in Monogamous and Polygamous Voles , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  W. Banks,et al.  Carrier-mediated transport of labeled oxytocin from brain to blood. , 1991, Neuroendocrinology.

[41]  L. D. van de Kar,et al.  Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. , 1991, The Journal of pharmacology and experimental therapeutics.

[42]  H. Björvell,et al.  Personality traits in women 4 days postpartum and their correlation with plasma levels of oxytocin and prolactin , 1990 .

[43]  R. Olson,et al.  MIF-1 is active in a chronic stress animal model of depression , 1989, Pharmacology Biochemistry and Behavior.

[44]  K. Uvnäs‐Moberg,et al.  Elevated plasma levels of oxytocin in obese subjects before and after gastric banding. , 1989, International journal of obesity.

[45]  A. Bertolini,et al.  Oxytocin acts as an antidepressant in two animal models of depression. , 1987, Life sciences.

[46]  A. Ermisch,et al.  On the blood-brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions. , 1985, Endocrinologia experimentalis.

[47]  Y. Shinomura,et al.  Plasma cholecystokinin responses after ingestion of liquid meal and intraduodenal infusion of fat, amino acids, or hydrochloric acid in man: analysis with region specific radioimmunoassay. , 1983, The American journal of gastroenterology.

[48]  S. Efendić,et al.  Sulphonylurea (glubenclamide) enhances somatostatin and inhibits glucagon release induced by arginine. , 1980, Acta physiologica Scandinavica.